VetStem receives immunotherapy license from human health firmJuly 15, 2019Biopharmaceutical animal health company VetStem has partnered with Calidi Biotherapeutics, a clinical‐stage biotechnology company specializing in the stem cell-based delivery of oncolytic virus-based immunotherapies for cancer.
SPONSORED CONTENTSee What the ACVIM Recommends for Certain Types of Canine CHFSafe, effective treatment that's approved by the FDA for management of certain types of canine CHF. + Learn More